Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism PKCδ inhibitors(Protein kinase C delta inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| KRAS G12C mutant Non-small Cell Lung Cancer | Preclinical | China | 30 Jun 2023 | |
| KRAS mutant Colorectal Cancer | Preclinical | China | 30 Jun 2023 | |
| KRAS Mutant Pancreatic Cancer | Preclinical | China | 30 Jun 2023 |





